DiaSorin slightly raises 2024 guidance following Q2 results

DiaSorin SpA

29/07/2024 15:14

July 29 (Reuters) - Italian medical diagnostics group
DiaSorin  DIAS.MI  on Monday slightly hiked guidance for 2024,
after its second quarter adjusted core profit rose 9% at a
constant exchange rate compared to the same period last yea.
    The company now expects for 2024 a growth in revenue
excluding Covid between 6%-7% compared to previous guidance of
5%-7% growth, and sees its 2024 adjusted core profit margin at
about 33% compared to a previous margin set at 32%-33%.

 (Reporting by Alberto Chiumento)
 ((Alberto.chiumento@thomsonreuters.com))